APOE and Cognitive impairment: Our results suggested that the odds of cognitive impairment was 17% (95% CI: 1% to 30%) lower among those APOE ε4 noncarriers (versus carriers) and 52% lower among those with healthy (versus unhealthy) lifestyle after controlling for sociodemographic, disability, and a number of chronic diseases.